Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin C Miller

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Bone Marrow Transplantation|August 18, 2018
Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myelomaKevin C Miller, Morie A Gertz, Francis K Buadi, et al.
Leukemia & Lymphoma|October 3, 2018
Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patientsKevin C Miller, Aref Al-Kali, Mithun V Shah, et al.
Current Sports Medicine Reports|September 7, 2023
Letter on the 2023 ACSM Expert Consensus Statement on Exertional Heat IllnessDouglas J Casa, Michael R Szymanski, John F Jardine, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|June 24, 2015
Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015Tamara Hew-Butler, Mitchell H Rosner, Sandra Fowkes-Godek, et al.
British Journal of Haematology|October 26, 2021
Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemiaZaid H Abdel Rahman, Ricardo D Parrondo, Michael G Heckman, et al.
British Journal of Sports Medicine|August 1, 2015
Statement of the 3rd International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015Tamara Hew-Butler, Mitchell H Rosner, Sandra Fowkes-Godek, et al.
Journal of Athletic Training|April 22, 2017
Round Table on Malignant Hyperthermia in Physically Active Populations: Meeting ProceedingsYuri Hosokawa, Douglas J Casa, Henry Rosenberg, et al.
Blood Cancer Journal|April 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myelomaHamza Hashmi, Tara Sebastian, Sridevi Rajeeve, et al.
Blood Advances|March 6, 2025
Restarting Teclistamab and Talquetamab after Prolonged Dose Delay May Not Require Re-Step-up DosingCarlyn R Tan, Alice X Wang, David Nemirovsky, et al.
Blood Advances|May 2, 2025
Outcomes in Frail Patients Receiving BCMA-directed Bispecific Antibodies for Relapsed/Refractory Multiple MyelomaBenjamin O Adegbite, Carlyn Rose Tan, Tala Shekarkhand, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Bone Marrow Transplantation|August 18, 2018
Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myelomaKevin C Miller, Morie A Gertz, Francis K Buadi, et al.
Leukemia & Lymphoma|October 3, 2018
Elderly acute lymphoblastic leukemia: a Mayo Clinic study of 124 patientsKevin C Miller, Aref Al-Kali, Mithun V Shah, et al.
Current Sports Medicine Reports|September 7, 2023
Letter on the 2023 ACSM Expert Consensus Statement on Exertional Heat IllnessDouglas J Casa, Michael R Szymanski, John F Jardine, et al.
Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine|June 24, 2015
Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015Tamara Hew-Butler, Mitchell H Rosner, Sandra Fowkes-Godek, et al.
British Journal of Haematology|October 26, 2021
Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemiaZaid H Abdel Rahman, Ricardo D Parrondo, Michael G Heckman, et al.
British Journal of Sports Medicine|August 1, 2015
Statement of the 3rd International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015Tamara Hew-Butler, Mitchell H Rosner, Sandra Fowkes-Godek, et al.
Journal of Athletic Training|April 22, 2017
Round Table on Malignant Hyperthermia in Physically Active Populations: Meeting ProceedingsYuri Hosokawa, Douglas J Casa, Henry Rosenberg, et al.
Blood Cancer Journal|April 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myelomaHamza Hashmi, Tara Sebastian, Sridevi Rajeeve, et al.
Blood Advances|March 6, 2025
Restarting Teclistamab and Talquetamab after Prolonged Dose Delay May Not Require Re-Step-up DosingCarlyn R Tan, Alice X Wang, David Nemirovsky, et al.
Blood Advances|May 2, 2025
Outcomes in Frail Patients Receiving BCMA-directed Bispecific Antibodies for Relapsed/Refractory Multiple MyelomaBenjamin O Adegbite, Carlyn Rose Tan, Tala Shekarkhand, et al.
Pageof 9